Carl L. Gordon - 04 Oct 2021 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: IRON
Reported as of: 04 Oct 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Oct 2021, 16:15:32 UTC
Prior SEC filing: 17 Jun 2021
Next SEC filing: 08 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ Jason Meyenburg, attorney-in-fact

Key filing fact

Carl L. Gordon filed Form 4 for Gemini Therapeutics, Inc. /DE (IRON) on 06 Oct 2021.

Key facts

This page summarizes Carl L. Gordon's Form 4 filing for Gemini Therapeutics, Inc. /DE (IRON).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Oct 2021, 16:15.

Change

Previous filing in this sequence was filed on 17 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRON transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +17,245
Change %
Price: $0.000000
Shares after: 17,245
Date: 04 Oct 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,245
Exercise price: $3.80
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date.

Footnote F2

Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP.